{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-007145","form_type":"8-K","ticker":"CPMD","cik":"0001081938","company_name":"CANNAPHARMARX, INC.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.151091+00:00","generated_at":"2026-06-09T23:48:45.754106+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CannaPharmaRX appoints Oliver Foeste as CFO; John Cassels departs without disagreement","bullets":["John Cassels replaced as CFO effective Oct 13, 2023; no disagreement with company on operations.","Oliver Foeste appointed CFO; founder of Invictus Accounting Group, CPA, senior finance roles at TSX, TSXV, NYSE issuers.","Foeste engaged in July 2023 for backup CFO services; compensation includes annual bonuses/stock options and hourly billing $65-$400.","No family relationships or material interests between Foeste and any director/officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-007145","json":"https://secwatch.observer/filing/0001683168-23-007145.json","markdown":"https://secwatch.observer/filing/0001683168-23-007145.md","text":"https://secwatch.observer/filing/0001683168-23-007145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/0001683168-23-007145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/cannapharmarx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:48:45.754106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b7937cbec","claim":"Oliver Foeste was appointed as Chief Financial Officer at CANNAPHARMARX, INC..","evidence_excerpt":"Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/0001683168-23-007145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"4055e6cd7e","claim":"John Cassels departed as Chief Financial Officer at CANNAPHARMARX, INC..","evidence_excerpt":"Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823007145/0001683168-23-007145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}